Revolution Medicines(RVMD) - 2024 Q3 - Earnings Call Transcript

Revolution Medicines, Inc. (NASDAQ:RVMD) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Ryan Asay – Senior Vice President-Corporate Affairs Mark Goldsmith – Chairman and Chief Executive Officer Steve Kelsey – President-Research and Development Jack Anders – Chief Financial Officer Wei Lin – Chief Medical Officer Conference Call Participants Peter Lawson – Barclays Michael Schmidt – Guggenheim Securities Jay Olson – Oppenheimer Marc Frahm – TD Cowen Alec Stranahan – Bank of ...